Task order feasibility of studying adverse events associated with bisphosphonate use
Ended Awarded Last action
- Contract number
- HHSF22301006T
- Awardee
-
Harvard Pilgrim Health Care, Inc. UEI NZVVQ8GNVX65
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $90,489
Award facts
- Contract value 100% obligated
- $90,489.26 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- PSC
- C118 Research And Development Facilities
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Wellesley Hills, Wellesley, MA 02481, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$9,577 | |
| Change Order | $0 | |
| Change Order | $0 | |
| Original award | $100,066 |
About this award
This is a firm fixed-price delivery order awarded by the Food and Drug Administration (FDA) to Harvard Pilgrim Health Care Inc.'s Office of Sponsored Programs division, a non-profit healthcare organization. The $90,489.26 contract supports a task order for the "Feasibility of Studying Adverse Events Associated with Bisphosphonate Use."
This contract is not associated with a set-aside designation. Harvard Pilgrim has extensive experience conducting public health research and data analytics services for federal agencies, including multi-million dollar contracts with the FDA to maintain and enhance the Sentinel System for post-market medical product safety monitoring. The organization also holds contracts with the Centers for Disease Control and Prevention (CDC) to support vaccine safety research through the Vaccine Safety Datalink program. Additionally, Harvard Pilgrim has a $275 million single-award IDIQ contract with the FDA to support the Sentinel Initiative through 2025, allowing the agency to issue task orders for continued development and enhancement of the Sentinel System.
Quick answers
Who was awarded contract HHSF22301006T?
HHSF22301006T was awarded to Harvard Pilgrim Health Care, Inc. by Food and Drug Administration (Department of Health and Human Services) on September 12, 2011.
How much is contract HHSF22301006T worth?
The government has obligated $90,489 on HHSF22301006T.
Is contract HHSF22301006T an order under another contract?
Yes. HHSF22301006T is a delivery order under HHSF223201000009I, an indefinite delivery contract.
Was contract HHSF22301006T competed?
The extent of competition for HHSF22301006T was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award